Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swarbrick

Showing results (501-510 of 641) with videos related to

Pageof 65
Sort By:
Endocrine-Related Cancer|December 18, 2018
Non-canonical AR activity facilitates endocrine resistance in breast cancerKeeMing Chia, Heloisa Milioli, Neil Portman, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 1, 2023
Activation of β-adrenergic receptor signaling prevents glucocorticoid-induced obesity and adipose tissue dysfunction in male miceManuel Gado, Annett Heinrich, Denise Wiedersich, et al.
Nature Aging|November 4, 2025
Cell populations in human breast cancers are molecularly and biologically distinct with ageAdrienne Parsons, Esther Sauras Colón, Meghana Manjunath, et al.
European Journal of Medicinal Chemistry|July 23, 2021
Amidoxime prodrugs convert to potent cell-active multimodal inhibitors of the dengue virus proteaseCrystall Swarbrick, Vasiliki Zogali, Kitti Wing Ki Chan, et al.
The Journal of General Virology|April 17, 2026
Structural insights into the nuclear import of ovine gammaherpesvirus 2 ORF73 LANA homologueBabu Kanti Nath, Renate H M Schwab, Crystall M D Swarbrick, et al.
Clinical Epigenetics|December 19, 2021
Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancerBraydon Meyer, Samuel Clifton, Warwick Locke, et al.
Cancer Research|July 25, 2014
Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancerThomas W Owens, Renee L Rogers, Sarah Best, et al.
Nature Communications|July 18, 2019
High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytesMandeep Singh, Ghamdan Al-Eryani, Shaun Carswell, et al.
BJU International|March 12, 2024
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancerDickon Hayne, Katherine Ong, Nicole Swarbrick, et al.
Scientific Reports|November 3, 2016
Adenovirally-Induced Polyfunctional T Cells Do Not Necessarily Recognize the Infected Target: Lessons from a Phase I Trial of the AERAS-402 VaccineMelissa Nyendak, Gwendolyn M Swarbrick, Amanda Duncan, et al.
Pageof 65

Showing results (501-510 of 641) with videos related to

Sort By:
Pageof 65
Endocrine-Related Cancer|December 18, 2018
Non-canonical AR activity facilitates endocrine resistance in breast cancerKeeMing Chia, Heloisa Milioli, Neil Portman, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 1, 2023
Activation of β-adrenergic receptor signaling prevents glucocorticoid-induced obesity and adipose tissue dysfunction in male miceManuel Gado, Annett Heinrich, Denise Wiedersich, et al.
Nature Aging|November 4, 2025
Cell populations in human breast cancers are molecularly and biologically distinct with ageAdrienne Parsons, Esther Sauras Colón, Meghana Manjunath, et al.
European Journal of Medicinal Chemistry|July 23, 2021
Amidoxime prodrugs convert to potent cell-active multimodal inhibitors of the dengue virus proteaseCrystall Swarbrick, Vasiliki Zogali, Kitti Wing Ki Chan, et al.
The Journal of General Virology|April 17, 2026
Structural insights into the nuclear import of ovine gammaherpesvirus 2 ORF73 LANA homologueBabu Kanti Nath, Renate H M Schwab, Crystall M D Swarbrick, et al.
Clinical Epigenetics|December 19, 2021
Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancerBraydon Meyer, Samuel Clifton, Warwick Locke, et al.
Cancer Research|July 25, 2014
Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancerThomas W Owens, Renee L Rogers, Sarah Best, et al.
Nature Communications|July 18, 2019
High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytesMandeep Singh, Ghamdan Al-Eryani, Shaun Carswell, et al.
BJU International|March 12, 2024
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancerDickon Hayne, Katherine Ong, Nicole Swarbrick, et al.
Scientific Reports|November 3, 2016
Adenovirally-Induced Polyfunctional T Cells Do Not Necessarily Recognize the Infected Target: Lessons from a Phase I Trial of the AERAS-402 VaccineMelissa Nyendak, Gwendolyn M Swarbrick, Amanda Duncan, et al.
Pageof 65